3 sources·Health

WHO Approves First Mpox Vaccine for Children Amid Outbreak in Congo

The WHO has authorized a new mpox vaccine for children to combat rising cases in Congo and help protect vulnerable populations.

67%

33%

The distribution of story sources: left-leaning (blue), center (light gray), and right-leaning (red).

Reliable

The underlying sources consistently report facts with minimal bias, demonstrating high-quality journalism and accuracy.

Balanced

The underlying sources are either a balanced mix of left and right or primarily centrist.

Subscribe to unlock this story

We really don't like cutting you off, but you've reached your monthly limit. At just $3/month or $30/year, subscriptions are how we keep this project going. Start your free 7-day trial today!

Get Started

No highlights available for this story.

Updated: Nov 20th, 2024, 10:17 AM ET

Summary

A summary of the key points of this story verified across multiple sources.

The WHO has approved the first mpox vaccine for children over one year old, developed by KM Biologics, as cases among minors surge in Congo. Experts stress the vulnerability of children to the disease, which has seen a 130% increase in suspected cases among those under 18. With over 46,000 suspected cases across Africa and a donation of 3 million vaccine doses from Japan, this decision aims to enhance immunization efforts during an alarming outbreak where children are disproportionately affected.

Perspectives

Compare opinions on this story from liberal (Left), conservative (Right) or center-leaning news organizations.

No center-leaning sources available for this story.